Zhang XY et al. – The brain–derived neurotrophic factor (BDNF) system may be implicated in the pathophysiology of tardive dyskinesia (TD) and its improvement with antioxidant treatment. Furthermore, patients with the genetic potential for greater BDNF release may obtain a greater reduction in TD from EGb–761 treatment. [more...]
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close